Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heng Liang

Showing results (461-470 of 479) with videos related to

Pageof 48
Sort By:
Journal of Medicinal Chemistry|July 25, 2003
Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligandsGang Liu, Zhili Xin, Heng Liang, et al.
Journal of the American Chemical Society|April 3, 2023
Doping Shortens the Metal/Metal Distance and Promotes OH Coverage in Non-Noble Acidic Oxygen Evolution Reaction CatalystsNing Wang, Pengfei Ou, Rui Kai Miao, et al.
Journal of Medicinal Chemistry|May 16, 2003
Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1BGang Liu, Bruce G Szczepankiewicz, Zhonghua Pei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid CancerKatherine D Gray, Jaclyn E McCloskey, Yogindra Vedvyas, et al.
Cell Communication and Signaling : CCS|October 15, 2025
Clinical implications of ctDNA-based minimal residual disease detection in newly diagnosed peripheral T-cell lymphoma: a single-center cohort studyJin-Hua Liang, Wei Hua, Hua Yin, et al.
Investigational New Drugs|October 5, 2010
Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agentsWen-Tai Li, Der-Ren Hwang, Jen-Shin Song, et al.
JCI Insight|April 20, 2017
Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infectionsYiu-Wing Kam, Cheryl Yi-Pin Lee, Teck-Hui Teo, et al.
Molecular Cancer Research : MCR|February 15, 2023
Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid CarcinomaJessica Limberg, Caitlin E Egan, Katherine D Gray, et al.
Cell Discovery|June 28, 2022
Phase separation of insulin receptor substrate 1 drives the formation of insulin/IGF-1 signalosomesXiu Kui Gao, Xi Sheng Rao, Xiao Xia Cong, et al.
Leukemia|May 15, 2024
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphomaJin-Hua Liang, Yi-Fan Wu, Hao-Rui Shen, et al.
Pageof 48

Showing results (461-470 of 479) with videos related to

Sort By:
Pageof 48
Journal of Medicinal Chemistry|July 25, 2003
Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligandsGang Liu, Zhili Xin, Heng Liang, et al.
Journal of the American Chemical Society|April 3, 2023
Doping Shortens the Metal/Metal Distance and Promotes OH Coverage in Non-Noble Acidic Oxygen Evolution Reaction CatalystsNing Wang, Pengfei Ou, Rui Kai Miao, et al.
Journal of Medicinal Chemistry|May 16, 2003
Discovery and structure-activity relationship of oxalylarylaminobenzoic acids as inhibitors of protein tyrosine phosphatase 1BGang Liu, Bruce G Szczepankiewicz, Zhonghua Pei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2020
PD1 Blockade Enhances ICAM1-Directed CAR T Therapeutic Efficacy in Advanced Thyroid CancerKatherine D Gray, Jaclyn E McCloskey, Yogindra Vedvyas, et al.
Cell Communication and Signaling : CCS|October 15, 2025
Clinical implications of ctDNA-based minimal residual disease detection in newly diagnosed peripheral T-cell lymphoma: a single-center cohort studyJin-Hua Liang, Wei Hua, Hua Yin, et al.
Investigational New Drugs|October 5, 2010
Synthesis and biological evaluation of 2-amino-1-thiazolyl imidazoles as orally active anticancer agentsWen-Tai Li, Der-Ren Hwang, Jen-Shin Song, et al.
JCI Insight|April 20, 2017
Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infectionsYiu-Wing Kam, Cheryl Yi-Pin Lee, Teck-Hui Teo, et al.
Molecular Cancer Research : MCR|February 15, 2023
Activation of the JAK/STAT Pathway Leads to BRAF Inhibitor Resistance in BRAFV600E Positive Thyroid CarcinomaJessica Limberg, Caitlin E Egan, Katherine D Gray, et al.
Cell Discovery|June 28, 2022
Phase separation of insulin receptor substrate 1 drives the formation of insulin/IGF-1 signalosomesXiu Kui Gao, Xi Sheng Rao, Xiao Xia Cong, et al.
Leukemia|May 15, 2024
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphomaJin-Hua Liang, Yi-Fan Wu, Hao-Rui Shen, et al.
Pageof 48